New Approach to Non-Invasive Assessment of Vascular Circulation Based on the Response to Transient Ischemia.

Introduction

The treatment of vascular diseases incurs tremendous cost to healthcare systems. Current approaches focus largely on managing symptoms. In the last decade, substantial evidence has linked vascular diseases with a dysfunctional response to hypoxia. A distinguishable reaction to hypoxia can be identified from macro- and microvessels. Based on this effect, we have developed a new, non-invasive diagnostic technique called Flow Mediated Skin Fluorescence (FMSF) to be used for assessment of vascular circulation and metabolic regulation.1 The FMSF technique has been successfully used for non-invasive diagnostics of many vascular diseases, including CVD, PAD, diabetes, and hypertension.2–4 The FMSF technique has also attracted a considerable interest among sports physiologists.5

One conclusion from our studies using the FMSF technique is that diagnostics of vascular circulation should focus not only on dysfunctional blood flow in major arteries, but also on microcirculatory responses to hypoxia. In this communication, we present two key parameters derived from FMSF measurements: Reactive Hyperemia Response (RHR) and Hypoxia Sensitivity [log(HS)]. These parameters can be used for efficient characterization of vascular circulation based on the response to transient ischemia.

Methods

Measurements were performed using the AngioExpert, a device constructed by Angionica Ltd. The AngioExpert device uses the Flow Mediated Skin Fluorescence (FMSF) technique, which measures changes in the intensity of nicotinamide adenine dinucleotide (NADH) fluorescence from the skin on the forearm in response to blocking and releasing blood flow. The skin is the largest organ of the human body, and is characterized by specific metabolism. The epidermal layer of the skin is not directly vascularized, and oxygen and nutrients are transported from the dermis by diffusion. Therefore, epidermal cell metabolism can be considered as a unique and sensitive marker of early dysfunction in vascular circulation and metabolic regulation.

The AngioExpert assesses the patient’s condition by analyzing changes in the NADH fluorescence signal emitted from epidermal cells in response to forced occlusion ischemia and subsequent hyperemia due to the removal of the occlusion. By interpreting the parameters and the shape of the obtained NADH fluorescence curve, disorders of the vascular circulation can be identified that may be indicative of chronic diseases. The AngioExpert measures the NADH fluorescence excited by ultraviolet (UV) radiation with a wavelength of 340 nm (UVB). As the maximum UVB penetration light of 340 nm is approximately 0.3–0.5 mm, the results are determined by NADH fluorescence within the epidermis. The emitted wavelength of NADH fluorescence is 460 nm (blue light). The test is performed in a comfortable sitting position, after a minimum adaptation period of 5 minutes, in a quiet room with a controlled air temperature (24 ± 1 °C). The resting NADH fluorescence value emitted by the epidermal layer of the forearm is recorded for the first 3 minutes (180 s). The brachial artery is then occluded by inflating the cuff of the device to 60 mmHg above the systolic pressure. The ischemic response is recorded over a period of 3 minutes (180 s). During this time, ischemic changes in the NADH fluorescence signal are recorded. Upon completion of the occlusion, the cuff pressure is released abruptly, restoring flow in the brachial artery and inducing a hyperemic response, for a minimum duration of 4 minutes (240 s).

RHR is a newly introduced parameter (defined in Figure 1), which characterizes endothelial function related predominantly to the production of nitric oxide (NO) in the vasculature due to reactive hyperemia. RHR is a unique parameter, based on the combined response from both the ischemic and hyperemic parts of the measured FMSF trace.

Figure 1

Definition of the RHR parameter.

The HS parameter has been used previously in the analysis of FMSF traces and represents a direct measure of the intensity of microcirculatory oscillations related to myogenic oscillations with frequencies in the range of 0.052–0.15 Hz, recorded during reperfusion.6,7 Myogenic microcirculatory oscillations are a very sensitive measure of the microcirculatory response to hypoxia, which can be monitored with high precision using the FMSF technique. As the values of the HS parameter can vary within a quite broad range it is more practical to use a normally distributed log(HS).

The study was conducted at the Medical University of Lodz, Poland, and Poznan University of Physical Education, Poland. It conformed to the principles outlined in the Declaration of Helsinki and the study protocol was approved by the University Bioethics Committee. All the subjects gave written informed consent prior to participation.

Results and Discussion

The results summarized in Figure 2 were collected for three studied groups: A – endurance athletes; B – healthy middle-aged individuals; C – diabetes type 2 patients. The RHR parameter distinguishes these three groups with high statistical significance. Such observations indicate that the use of RHR parameter has adequate sensitivity to be used for characterization of vascular circulation. A similar conclusion can be formulated based on analysis of the log(HS) parameter, representing reaction of microcirculation to transient hypoxia. The parameters RHR and log(HS) describe quite distinctive properties of the vascular system, and both parameters should be used jointly for effective diagnostics. Some correlation exists between the log(HS) and RHR parameters for healthy individuals (groups A + B), as shown in Figure 2D. However, these parameters should be interpreted separately when analyzing the patients with various diseases and disorders of vascular origin. For example, very low values (below 1) for the log(HS) parameter can effectively predict a limited chance for healing in patients with diabetic foot ulcers, regardless of the measured value of the RHR parameter.4 Diagnostic use of the RHR parameter can be greater in CVD, where dysfunction in macrocirculation prevails.

Figure 2

Assessment of RHR and log(HS) parameters in groups A, B, and C: A - highly trained endurance athletes (long-distance runners – 22, triathletes – 14, rowers – 14), n = 50 (33 m, 17 f), mean age 22.0 (16–35 y.); B - healthy middle-aged individuals, n = 32 (19 m, 13 f), mean age 38.2 (30–50 y.); C - diabetes type 2 patients, n = 70 (40 m, 32 f), mean age 63.1 (45–80 y.). Statistical analysis of differences between the parameters in the compared groups was based on the one-way ANOVA test with the Scheffe post hoc test. (A) Statistical differentiation of groups A, B, and C based on the RHR parameter. (B) Distribution of the RHR parameter. (C) Statistical differentiation of groups A, B, and C based on the log(HS) parameter. (D) Correlation between the log(HS) and RHR parameters for groups A + B (Pearson correlation).

Based on our experience using the FMSF diagnostic technique, we conclude that characterization of vascular circulation based on the RHR and log(HS) parameters can be effective across a broad segment of the population, from physically active healthy individuals to individuals suffering from serious health problems related to vascular dysfunctions. We believe that this simple two-parametric approach based on distinguishable macro- and microcirculatory responses to hypoxia will be recognized in the near future as a powerful diagnostic tool for characterization of vascular circulation.